Drug-induced liver injury
Author:
- Guruprasad P. AithalGAGuruprasad P. Aithal
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Human leukocyte antigen genetic risk factors of drug-induced liver toxicologyExpert Opinion on Drug Metabolism & Toxicology, 2014
- Genetic Basis of Drug-Induced Liver Injury: Present and FutureSeminars in Liver Disease, 2014
- Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of IcelandGastroenterology, 2013
- High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injuryHepatology, 2012
- Case Definition and Phenotype Standardization in Drug-Induced Liver InjuryClinical Pharmacology & Therapeutics, 2011
- Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injuryJournal of Hepatology, 2010
- Mitochondrial and Immunoallergic Injury Increase Risk of Positive Drug Rechallenge After Drug-Induced Liver InjuryHepatology, 2010
- Preempting and preventing drug-induced liver injuryNature Genetics, 2010
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinNature Genetics, 2009
- Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signalsHepatology, 2008